Commonly prescribed glucose-lowering agents included biguanides (64%), sodium-glucose cotransporter 2 (SGLT2) inhibitors (62%), and insulin (24%)
Neither is an approved treatment for growth hormone deficiency today
Despite this, CSII users experienced lower rate of hypoglycaemia events, shorter duration of DKA and length of hospital admission vs MDI (p 6 months (p-value 70% time in range 70-180mg/dL (52% vs 69%, p 140 mg/dL)
Original Publication Date: January 23, 2024 Last Updated: May 16, 2024 These data come from Cosmos, a collaboration of 236 Epic health systems representing more than 227 million patient records from 1,301 hospitals and more than 28,600 clinics from all 50 states and Lebanon
Collectively, selenium and zinc oxide nanoparticles demonstrate promising protective effects against diabetes-induced testicular oxidative damage and sperm dysfunction